Yüklüyor......
Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women
BACKGROUND: Tamoxifen can reduce the risk of developing invasive estrogen-receptor positive (ER+) breast cancer by 49%, but it is unknown how many women in the U.S. are taking tamoxifen for primary prevention of breast cancer. METHODS: Data from the years 2000 and 2005 National Health Interview Surv...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3038785/ https://ncbi.nlm.nih.gov/pubmed/20142242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-09-0930 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|